Benzodiazepines in acute psychosis: short-term tool, long-term risk

The first night of a psychiatric admission often involves a dose of lorazepam. So does an emergency-room visit for agitation. So does the management of catatonia. Benzodiazepines have a real, defensible place in acute psychiatric care. The problem is that "short-term" too often becomes "five years on a daily prescription nobody questions any more". Honest use of benzodiazepines requires honesty about both their value and their cost.

What benzodiazepines do

Benzodiazepines bind to the GABA-A receptor and amplify the calming effect of GABA, the brain's main inhibitory neurotransmitter. Clinically, this produces:

• Sedation
• Reduced anxiety
• Muscle relaxation
• Anticonvulsant effects

They do not directly treat psychotic symptoms. A benzodiazepine will not silence voices or resolve delusions. What it does is reduce the distress, agitation, and arousal that often accompany psychosis, particularly during a first episode or acute relapse.

Where short-term use is reasonable

Acute agitation

In emergency departments and inpatient units, intramuscular lorazepam (often combined with an antipsychotic such as haloperidol or olanzapine) is one of the most commonly used interventions for severe behavioural disturbance. It works within 15 to 30 minutes. For a calmer review of de-escalation more broadly, see de-escalation techniques in psychosis.

Catatonia

This is one place where benzodiazepines are not just helpful but front-line. Catatonia, with its immobility, mutism, posturing, and waxy flexibility, often responds dramatically to lorazepam — sometimes within minutes. The "lorazepam challenge" is a recognised diagnostic and therapeutic step.

Severe insomnia in acute episodes

During an acute episode, sleep can collapse entirely. A short course of a benzodiazepine to restore sleep may help short-circuit the relapse cycle, in which sleep loss worsens psychosis and psychosis worsens sleep loss.

Akathisia

Benzodiazepines can blunt the distress of akathisia, particularly in the short term. They are generally not first-line — see propranolol and mirtazapine — but in acute settings they are sometimes used while waiting for those agents to take effect.

Adjunct in early antipsychotic treatment

Many clinicians use a brief benzodiazepine course in the first one to two weeks of antipsychotic treatment to manage anxiety while the antipsychotic builds up. Tapered off thereafter, this can be a reasonable approach.

The long-term risks

Where benzodiazepines become dangerous is when "brief" turns into "indefinite". Several converging lines of evidence have raised serious concern about long-term benzodiazepine use in schizophrenia:

• Increased mortality: A series of large Scandinavian register studies, including work by Tiihonen and colleagues, has consistently shown higher all-cause mortality in people with schizophrenia on long-term benzodiazepines compared to those on antipsychotics alone.
• Cognitive impairment: Chronic use is associated with worse memory and processing speed, often persisting after discontinuation.
• Falls and fractures: Particularly in older adults.
• Tolerance and dependence: Both physiological and psychological. Stopping after long use can produce a withdrawal syndrome that is uncomfortable, sometimes prolonged, and occasionally dangerous (seizures).
• Respiratory depression: Especially when combined with opioids, alcohol, or pregabalin/gabapentin.

The medications you will see most often

• Lorazepam — the workhorse for acute agitation and catatonia; available oral, IM, and IV; intermediate half-life
• Diazepam — long half-life, useful for taper schedules
• Clonazepam — long-acting, sometimes used for chronic anxiety or akathisia (controversial)
• Alprazolam — short-acting, high dependence risk, generally avoided in schizophrenia

How to think about a current prescription

If you or your loved one has been on a benzodiazepine for more than a few months, it is worth a genuine conversation with the prescriber:

• Why was it started, and is that reason still relevant?
• What would the plan be to taper, and over what timeframe?
• Are there alternatives that haven't been tried (CBT for insomnia, beta-blockers for anxiety, mirtazapine, hydroxyzine)?

Tapers are usually slow — sometimes a 5 to 10% dose reduction every two to four weeks, sometimes slower. Slow is almost always better than fast.

Special situations

Older adults

Benzodiazepines in older adults dramatically increase the risk of falls, hip fracture, delirium, and possibly long-term cognitive decline. They are on the Beers Criteria list of medications generally to avoid in people over 65.

Substance use history

People with a history of opioid, alcohol, or sedative use disorders are at particularly high risk of benzodiazepine misuse and overdose. Most clinicians will use them very cautiously, if at all, in this group.

Pregnancy

First-trimester benzodiazepine use has been associated with a small possible increase in cleft palate risk; late-pregnancy use can cause neonatal sedation and withdrawal. Discuss with a perinatal psychiatrist when relevant.

The honest summary

Benzodiazepines are not the enemy. Used briefly and thoughtfully, they help patients through acute crises that would otherwise be more dangerous. The harm comes from drift — the prescription that nobody re-evaluates, the patient who quietly accumulates tolerance, the loved one who never quite gets off them. The single most important question to keep asking is: is this still helping, and is the plan to stop?

This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.